OMERS Administration Corp’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

OMERS Administration Corp’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-87,056	Closed	-$7.66M	–	391
2019 Q4	$7.66M	Buy	87,056 +47,356	+119%	+$3.99M	0.09%	133
2019 Q3	$3M	Buy	39,700 +9,100	+30%	+$739K	0.03%	243
2019 Q2	$2.65M	Buy	30,600 +28,500	+1,357%	+$2.82M	0.03%	249
2019 Q1	$235K	Buy	+2,100	New	+$209K	﹤0.01%	341

Other funds holding TARO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

OMERS Administration Corp's TARO Position: Q1 2020 in Review

OMERS Administration Corp sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2020, closing a stake of 87,056 shares — an estimated $7.66M sold.

OMERS Administration Corp first reported a position in TARO in Q1 2019 and held it in 4 quarters. The position peaked at $7.66M in Q4 2019. 90 funds tracked by Wall St. Rank hold TARO as of Q1 2020.

OMERS Administration Corp reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2020 after selling out during the quarter.
OMERS Administration Corp sold 87,056 Taro Pharmaceutical Industries Ltd. shares in Q1 2020, an estimated $7.66M.
OMERS Administration Corp first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2019 and held it in 4 quarters.
OMERS Administration Corp's Taro Pharmaceutical Industries Ltd. position peaked at $7.66M in Q4 2019.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2020.

Based on OMERS Administration Corp's 13F filing for Q1 2020, filed 15 May 2020.